Phase II study of erlotinib in patients with locally advanced or metastatic papillary histology renal cell cancer: SWOG S0317

Michael S. Gordon, Michael Hussey, Raymond B Nagle, Primo N. Lara, Philip C. Mack, Janice Dutcher, Wolfram Samlowski, Joseph I. Clark, David I. Quinn, Chong Xian Pan, David Crawford

Research output: Contribution to journalArticle

78 Scopus citations
Original languageEnglish (US)
Pages (from-to)5788-5793
Number of pages6
JournalJournal of Clinical Oncology
Volume27
Issue number34
DOIs
Publication statusPublished - Dec 1 2009
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Phase II study of erlotinib in patients with locally advanced or metastatic papillary histology renal cell cancer : SWOG S0317. / Gordon, Michael S.; Hussey, Michael; Nagle, Raymond B; Lara, Primo N.; Mack, Philip C.; Dutcher, Janice; Samlowski, Wolfram; Clark, Joseph I.; Quinn, David I.; Pan, Chong Xian; Crawford, David.

In: Journal of Clinical Oncology, Vol. 27, No. 34, 01.12.2009, p. 5788-5793.

Research output: Contribution to journalArticle